Variant report

Variant	rs8094790
Chromosome Location	chr18:29161620-29161621
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 13 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:7)

rs_ID	r²[population]
rs1667236	0.80[ASN][1000 genomes]
rs1667242	1.00[EUR][1000 genomes]
rs1791219	0.80[ASN][1000 genomes]
rs1791220	1.00[EUR][1000 genomes];0.80[ASN][1000 genomes]
rs59882235	1.00[EUR][1000 genomes]
rs7239174	1.00[MEX][hapmap]
rs73954631	1.00[EUR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:6 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1066692	chr18:28856066-29190505	Strong transcription Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	15 gene(s)	inside rSNPs	diseases
2	nsv543674	chr18:28856066-29190505	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Active TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	15 gene(s)	inside rSNPs	diseases
3	nsv916545	chr18:28898800-29166364	Enhancers Weak transcription Flanking Active TSS Strong transcription Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	14 gene(s)	inside rSNPs	diseases
4	nsv833615	chr18:29008396-29192976	Strong transcription Weak transcription Enhancers Active TSS ZNF genes & repeats Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	11 gene(s)	inside rSNPs	diseases
5	nsv576636	chr18:29146822-29190174	Enhancers Genic enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region	2 gene(s)	inside rSNPs	diseases
6	nsv1066881	chr18:29149752-29180840	Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Strong transcription	TF binding region CpG island	1 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:29 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr18:29156400-29163200	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
2	chr18:29158000-29162400	Enhancers	Fetal Intestine Large	intestine
3	chr18:29159200-29163400	Enhancers	Primary hematopoietic stem cells	blood
4	chr18:29159200-29163400	Enhancers	Primary hematopoietic stem cells short term culture	blood
5	chr18:29159400-29166400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
6	chr18:29159800-29166200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
7	chr18:29160000-29161800	Weak transcription	Placenta	Placenta
8	chr18:29160200-29163800	Enhancers	Liver	Liver
9	chr18:29160600-29161800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
10	chr18:29160800-29164600	Enhancers	HepG2	liver
11	chr18:29161000-29162200	Enhancers	Fetal Intestine Small	intestine
12	chr18:29161000-29162200	Enhancers	HSMMtube	muscle
13	chr18:29161000-29162600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
14	chr18:29161000-29163800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
15	chr18:29161000-29167000	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
16	chr18:29161400-29161800	Enhancers	Rectal Smooth Muscle	rectum
17	chr18:29161400-29162000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
18	chr18:29161400-29162200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
19	chr18:29161400-29162200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
20	chr18:29161400-29162200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
21	chr18:29161400-29162200	Enhancers	HUVEC	blood vessel
22	chr18:29161400-29162600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
23	chr18:29161600-29161800	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
24	chr18:29161600-29161800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
25	chr18:29161600-29162200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
26	chr18:29161600-29162200	Enhancers	Placenta Amnion	Placenta Amnion
27	chr18:29161600-29162200	Enhancers	NHEK	skin
28	chr18:29161600-29162400	Enhancers	Colon Smooth Muscle	Colon
29	chr18:29161600-29166400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links